However, most of the changes in B cell immune profiles are independent of the three genotypes in ET patients, and the activation of JAK-STAT signaling pathway can be seen in most ET patients regardless of their molecular profiles [40]. The gene discussed is SOAT1; the disease is essential thrombocythemia.